This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Labor shortages and other headwinds have battered hospices during 2022, including large companies. This has been a longstanding problem since the start of the pandemic, but average length of stay among the publicly traded firms tumbled at a faster rate in Q3 2022 (3%) than they did in the third quarter of 2021 (2%).
In 2022, the hospice community laid the groundwork for a transformational 2023. During late 2021 and 2022, the U.S. Centers for Medicare & Medicaid Services (CMS) developed new approaches for enforcing hospice regulations that will become effective on Jan. 3–6 Big Provider, Payer Hospice Deals.
Though hospice deal volume dipped in 2022 compared to previous years, five particular transactions could paint a larger picture of where investors see value in the space. These interesting, unusual or groundbreaking deals could signal what’s to come in 2023 and help shape the hospice market’s long-term future. s (NYSE: HUM) $2.8
Referral rejection rates among hospices reached a record high of 41% in 2022, according to data from CarePort, a WellSky company. While some hospicecompanies reported hiring and capacity gains in 2023, often driven by bonus programs, the problem persists for many providers.
In January, hospice organizations began sounding the alarm on similar activity in other states — Arizona, Texas and Nevada. Arizona had 239 new Medicare-certified hospices appear between 2018 and 2022, representing 52% of all providers in the state.
The Texas-based home health and hospicecompany VitalCaring Group was built largely through acquisitions, and the company expects to step up that strategy in 2024 with an emphasis on hospice. VitalCaring VitalCaring VitalCaring President Luke James We spoke early last year about VitalCaring’s launch.
Signatories on the joint letter included LeadingAge, the National Association for HomeCare & Hospice (NAHC), the National Hospice and Palliative Care Organization (NHPCO), and the National Partnership for Healthcare and Hospice Innovation (NPHI). NYSE: EHAB), Bayada Home Health Care and Amedisys Inc.
Through the hospice benefit, Medicare covers nearly 90% of a provider’s patient care revenue. This makes hospice billing for patient care a different reimbursement beast for other health care providers to tackle. High price tags for hospice assets are sparking some to take a seat at the sellers’ table.
Having a window into priorities such as career development and work-life balance is a significant retention factor for the Dallas-based home health and hospicecompany, Marion indicated. This is down from 54% of respondents in 2023’s survey and 68% of 2022 respondents. NYSE: EHAB).
Regardless of providers’ disparate methods, hospice remains a high-growth industry, expanding at an annual rate of 7% to 8% annually, Bank of America (BofA) Global Research reported in TKTK. By 2030, the hospice market’s total dollar value is expected to nearly double, reaching $64.7 billion, up from $34.5
The organizations penned a joint letter to CMS in November urging for increased oversight to help curb hospice frauds, including the National Association for HomeCare & Hospice (NAHC), National Hospice and Palliative Care Organization (NHPCO), National Partnership for Healthcare and Hospice Innovation (NPHI) and LeadingAge.
For Immediate Release January 19, 2023 Concerned by Growth of Unscrupulous Operators, Organizations Outline Areas of Focus, Key Steps (Alexandria, VA and Washington, D.C.) – The four national hospice provider organizations: LeadingAge , the National Association for HomeCare & Hospice (NAHC) , the National Hospice and Palliative Care Organization (..)
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content